US Bancorp DE Purchases 13,305 Shares of Oscar Health, Inc. (NYSE:OSCR)

US Bancorp DE increased its stake in Oscar Health, Inc. (NYSE:OSCR) by 115.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 24,784 shares of the company’s stock after purchasing an additional 13,305 shares during the period. US Bancorp DE’s holdings in Oscar Health were worth $526,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Point72 Hong Kong Ltd acquired a new stake in Oscar Health during the 2nd quarter valued at approximately $78,000. Quest Partners LLC purchased a new position in shares of Oscar Health during the 2nd quarter valued at approximately $93,000. Amalgamated Bank increased its holdings in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock valued at $106,000 after purchasing an additional 1,458 shares in the last quarter. Optimum Investment Advisors purchased a new position in shares of Oscar Health during the 3rd quarter valued at approximately $142,000. Finally, Farallon Capital Management LLC purchased a new position in shares of Oscar Health during the 1st quarter valued at approximately $164,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on OSCR shares. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. UBS Group assumed coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target for the company. Finally, Piper Sandler reissued an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.93.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Ranmali Bopitiya sold 36,175 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $650,788.25. Following the sale, the executive vice president now directly owns 251,885 shares in the company, valued at approximately $4,531,411.15. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock valued at $3,007,069 over the last 90 days. 25.11% of the stock is owned by insiders.

Oscar Health Trading Up 1.9 %

Shares of OSCR stock opened at $13.80 on Tuesday. The company’s 50-day moving average price is $18.45 and its 200-day moving average price is $18.36. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock has a market cap of $3.34 billion, a price-to-earnings ratio of -230.00, a PEG ratio of 31.17 and a beta of 1.67. Oscar Health, Inc. has a twelve month low of $6.80 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.91%. The company had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same period in the previous year, the company earned ($0.29) EPS. The company’s quarterly revenue was up 68.3% compared to the same quarter last year. As a group, equities analysts predict that Oscar Health, Inc. will post 0.02 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.